openPR Logo
Press release

JAMA Psychiatry meta-analysis confirms deprexis efficacy

02-27-2017 03:33 PM CET | Health & Medicine

Press release from: GAIA AG

/ PR Agency: Crowdfluence Ltd
Jama Psychiatry meta-analysis confirms deprexis efficacy

Jama Psychiatry meta-analysis confirms deprexis efficacy

* Gaia AG’s self-guided internet-based cognitive behavioral therapy effective in treating depressive symptoms *

Hamburg, Germany: GAIA AG, a global pioneer in digital therapy, announced today that deprexis®, a web-based EC- and FDA-cleared medical device developed by GAIA, has once again been proven to be effective in a global scientific study.

A new meta-analysis of individual patient data, published in the latest issue of JAMA Psychiatry, confirmed the efficacy of deprexis® for the treatment of depression. The software is one of GAIA’s developments. It has recently been licensed to Servier globally, except for the US and Japan. The meta-analysis was a truly global collaborative effort, as 26 researchers from the Netherlands, the US, UK, Australia, Germany, Switzerland, and Spain combined data from 13 randomized controlled trials with a total of 3876 study participants. Of the 13 trials, 5 had examined deprexis (38%), and 1199 of the participants came from deprexis studies (31%). There were no other interventions from Germany. The average effect size reported for deprexis studies was 0.53, compared to 0.28 for others.

“We are very pleased with the results of this meta-analysis. It confirms the results of previous randomized controlled trials (RCTs) on deprexis®,” added Mario Weiss, CEO and founder of GAIA. “Depression is a widely-spread pathology, with around 350 million people worldwide suffering from it (WHO). Patients benefit greatly from deprexis® as an adjunct therapy, in addition to pharmacologic or psychotherapeutic treatments.”

GAIA is a global leader in digital therapeutics. With its stringent focus on research and development of evidence based online interventions the company continuously shifts benchmarks when it comes to effect sizes and safety profiles for digital therapeutics in neuroscience. With more than 100 experts in the field of Medicine, Psychology, Behavioral Medicine, Software Engineering, as well as Regulatory and Market Access, GAIA is a key partner in the development of next generation digital solutions to support and treat patients with a broad variety of medical conditions.

More information: http://gaia-group.com/en

Crowdfluence Ltd (on behalf of Gaia AG)
1st Floor Healthaid House
Marlborough Hill
Harrow
Midxx HA1 1UD
UK
E-mail: suhela@crowdfluence.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release JAMA Psychiatry meta-analysis confirms deprexis efficacy here

News-ID: 450936 • Views: 685

More Releases from GAIA AG

03-03-2017 | Health & Medicine
GAIA AG
Antidepressant digital therapy (deprexis®) effective in the US
New trial confirms effectiveness of Gaia AG’s computer-based therapy deprexis with impressive effect size. Hamburg, Germany: GAIA AG, a global pioneer in digital therapy, announced today that deprexis®, a software developed by Gaia, has been demonstrated to be effective in a scientific study in the US. A randomized controlled trial (RCT) with N = 376 depressed adults, published in the latest issue of the Journal of Consulting and Clinical
07-30-2010 | Health & Medicine
GAIA AG
Individual Online Help for Depression
Depression is a common and growing disease. People who suffer from such a mental disease are often confronted with additional problems, both in their private and professional lives, as well as in their finances. Losing one’s job, friends and spending a lot of money for high-cost treatment like psychotherapy and medication at the same time add even more pressure to one’s already unhappy circumstances. And this is only the tip of

More Releases for Psychiatry

DreamCloud Psychiatry "Keeps It Real" In Telemedicine
New York, NY - A small company called DreamCloud Psychiatry based in Miami Beach, Florida, is looking to change the way mental health providers deliver virtual medical services. Chris Lee, its founder, wanted to create a solution to what he calls "one of telemedicine's greatest challenges," which is "keeping it real." "The most important part of a patient-provider relationship in telemedicine is maintaining a connection that feels real," says Lee. "If
Psychiatry Therapies Market Present Insights into Opportunities & Threats 2014 …
Psychiatric therapies include therapeutic interaction processes between trained psychiatric professionals and the patient in order to treat psychology related problems of patients. Psychiatric therapies involve the treatment of emotional and mental disorders and behavior disturbance by using psychological techniques and therapies. These psychiatry therapies are designed to change the behavior of a patient and provide relief from the disorder. Psychiatry therapies basically rely on establishing relationship between patients and psychiatry therapist
Psychiatry Therapies Market To Observe Strong Development By 2020
Psychiatric therapies include therapeutic interaction processes between trained psychiatric professionals and the patient in order to treat psychology related problems of patients. Psychiatric therapies involve the treatment of emotional and mental disorders and behavior disturbance by using psychological techniques and therapies. These psychiatry therapies are designed to change the behavior of a patient and provide relief from the disorder. Psychiatry therapies basically rely on establishing relationship between patients and psychiatry therapist
27th International Conference on Psychiatry & Psychology Health
27th International Conference on Psychiatry & Psychology Health June 18-19, 2018 Paris, France Theme : Embracing the Excellency in Neuroscience and Mental Health Make it count in your professional life. Attend Psychiatry & Psychology Health Conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. Accepted abstracts will be labeled with a Digital Object Identification Number (DOI) provided
World Summit on Psychiatry and Mental Health Nursing
Welcome to World Summit on Psychiatry and Mental Health Nursing scheduled to be held during November 26-27, 2018 at Los Angeles, California, USA with a theme “Improving Practice and Optimizing Recovery towards Psychiatric and Mental Health Nursing”. The primary objective of this conference is to bring together psychiatry and nursing professionals from around the world with a focus on the regional issues related to mental health. This event creates a
Psychiatry Therapies Market with Global Industry Analysis to 2020
Psychiatric therapies include therapeutic interaction processes between trained psychiatric professionals and the patient in order to treat psychology related problems of patients. Psychiatric therapies involve the treatment of emotional and mental disorders and behavior disturbance by using psychological techniques and therapies. These psychiatry therapies are designed to change the behavior of a patient and provide relief from the disorder. Psychiatry therapies basically rely on establishing relationship between patients and psychiatry